Company / Capital Returned to Shareholders
ANI Pharmaceuticals, Inc. Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$13.4M
FY2025
5-year range
$1.1M / $13.4M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#40 of 52
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s capital returned to shareholders of $13M is lower than 77% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has increased for 4 consecutive years, from $1M in FY2021 to $13M in FY2025.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of +54.4%.
Improved from $7M to $13M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +55.1%
- 5-Year CAGR
- +54.4%
- 10-Year CAGR
- -
Sector benchmark
-99.0% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s capital returned to shareholders has grown for 4 consecutive years.
- 5-year CAGR of +54.4%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 6.2% year-over-year.
- Ranks #40 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.4M | +6.2% |
| FY2024 | $12.6M | +90.3% |
| FY2023 | $6.6M | +84.5% |
| FY2022 | $3.6M | +231.9% |
| FY2021 | $1.1M | -29.1% |
| FY2020 | $1.5M | +47.7% |
| FY2019 | $1.0M | - |
| FY2018 | $0 | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $2.5M | +477.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026